Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
NCT03747614 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-11-20
Summary
Dry eye disease (DED), as one of the most common ocular surface diseases that affecting visual acuity, is highly associated with ocular surface inflammation. Until now, there is no accurate quantization index system to evaluate real-time ocular surface inflammation. Besides, an individualized therapy for ocular surface inflammation is also badly needed. As we all know, conjunctival congestion is one of the important clinical appearance of ocular surface inflammation. Hence, we suggest that several specific microvascular indexes could measure the change of ocular surface inflammation. Our program is aiming to investigate the correlation between inflammatory factors and blood flow velocity as well as microvascular distribution detecting from bulbar conjunctiva through our own devices and software.Futhermore, we tend to compare ocular surface microvascular indexes and microvascular distribution in normal people and dry eye patients in order to establish a database for Chinese people. By confirming the relationship between ocular surface microvascular indexes and ocular inflammation, we hope to set up new diagnostic criteria for ocular inflammation and an individualized therapeutic regimen based on ocular surface microvascular indexes. Finally, we want to establish a precision diagnostic and therapeutic pattern for dry eye disease.
Conditions
- Dry Eye Syndromes
- Inflammation
- Microvessels
Interventions
- DRUG
-
Fluorometholone
Fluorometh010neEyeDrops: Brand names: Allergan Pharmaceuticals Ireland, Serial number: J20130061, NDC 60758-880-05. Tacrolimus Brand names: Senju Pharmaceutical Co., Ltd. Fukusaki Plant Serial number: H20130452
- DEVICE
-
Functional Slit-Lamp Biomicroscopy
A traditional slit lamp (HAAG-STREIT SWISS MADE 900.7.2.34925) was used, and a digital camera (Canon 60D. Canon Inc, Melville, NY) was attached via an inherent camera port. Custom software was used to measure the conjunctival microvascular BFV and vessel diameter using a protocol that has been previously described in detail. At baseline, video clips were recorded on six fields of the bulbar conjunctiva, which was approximately 1 mm from the limbus. During the follow-up visits, attention was given to relocating the vessel segments for these 6 fields.
Sponsors & Collaborators
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-30
- Primary Completion
- 2020-06-30
- Completion
- 2020-06-30
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Dry Eye Evaluation System Based on Bioinformatics
NCT04109170 ·Status: UNKNOWN
-
Diadenosine Polyphosphates and Mucin Associated With Ocular Surface Disorders
NCT03731624 ·Status: UNKNOWN
-
Au-Ag-Cu2O NG With PTT Anti Drug-resistant Microbial Keratitis
NCT05268718 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients
NCT02712762 ·Status: COMPLETED
-
Lenticule Implantation and Autologous Serum New Approach in Treatment of Adenoviral Keratitis Disease
NCT05123014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impairment of Reading Ability in Dry Eye Patients
NCT01826812 ·Status: COMPLETED
-
Objective Measurements of Prolonged Effects of Restasis on Dry Eye Disease
NCT00567177 ·Status: COMPLETED ·Phase: PHASE4
-
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
NCT05131152 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)
NCT02051023 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Mucin Levels at the Ocular Surface of Visual Display Users With and Without Dry Eye Disease
NCT05604651 ·Status: COMPLETED
-
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
NCT01276223 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study of Smile Exercise for Dry Eye
NCT04421300 ·Status: COMPLETED ·Phase: NA
-
Influencing Factors on Dry Eye Syndrome and Ocular Surface Disease
NCT03364322 ·Status: COMPLETED
-
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
NCT04711642 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
NCT06655441 ·Status: RECRUITING ·Phase: PHASE4
-
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539 ·Status: UNKNOWN ·Phase: NA
-
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
NCT05255016 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease
NCT05784519 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
NCT02958514 ·Status: COMPLETED ·Phase: NA
-
Ocular Surface Microbiome in Dry Eye Patients
NCT02161341 ·Status: COMPLETED
-
Study of Platelet Rich Plasma Drops to Moderate Clinically Significant Dry Eye
NCT05121493 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
NCT00129077 ·Status: COMPLETED ·Phase: NA
-
Managing Dry Eye in Patients Using Glaucoma Drops
NCT06158984 ·Status: COMPLETED ·Phase: NA
-
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
NCT05713981 ·Status: COMPLETED ·Phase: NA